5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one

C108H100F8N18O13 — CID 157110327

About 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one

5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one (PubChem CID 157110327) has the molecular formula C108H100F8N18O13 and a molecular weight of 2010.08 g/mol. Its IUPAC name is 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one.

Molecular Properties

• Compound Name: 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one
• PubChem CID: 157110327
• Molecular Formula: C108H100F8N18O13
• Molecular Weight: 2010.08 g/mol
• Exact Mass: 2008.76
• IUPAC Name: 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one
• SMILES: CCOC(=O)Oc1ccc(-c2nc3c(c(C)nn3C(=O)OCC)c3c2c(=O)[nH]c2cc(N4CCN(C(=O)OCC)CC4)ccc23)cc1.CCOc1[nH]c2cc(N3CCCCC3)ccc2c2c1c(-c1ccc(O)c(C(F)(F)F)c1)nc1ncc(C)c12.CCn1c(=O)c2c(-c3ccc(O)c(C(F)(F)F)c3)nc3[nH]cc(C)c3c2c2ccc(N3CCCCC3)cc21.Cc1[nH]nc2nc(-c3cc(F)cc(F)c3)c3c(=O)n(C)ccc3c12
• InChI: InChI=1S/C33H34N6O8.2C29H27F3N4O2.C17H12F2N4O/c1-5-44-31(41)38-16-14-37(15-17-38)21-10-13-23-24(18-21)34-30(40)27-26(23)25-19(4)36-39(32(42)45-6-2)29(25)35-28(27)20-8-11-22(12-9-20)47-33(43)46-7-3;1-3-36-21-14-18(35-11-5-4-6-12-35)8-9-19(21)24-23-16(2)15-33-27(23)34-26(25(24)28(36)38)17-7-10-22(37)20(13-17)29(30,31)32;1-3-38-28-25-24(19-9-8-18(14-21(19)34-28)36-11-5-4-6-12-36)23-16(2)15-33-27(23)35-26(25)17-7-10-22(37)20(13-17)29(30,31)32;1-8-13-12-3-4-23(2)17(24)14(12)15(20-16(13)22-21-8)9-5-10(18)7-11(19)6-9/h8-13,18H,5-7,14-17H2,1-4H3,(H,34,40);7-10,13-15,37H,3-6,11-12H2,1-2H3,(H,33,34);7-10,13-15,34,37H,3-6,11-12H2,1-2H3;3-7H,1-2H3,(H,20,21,22)
• InChIKey: PYIRJEOLXKHZBG-UHFFFAOYSA-N
• XLogP: 22.38
• TPSA: 370.17 Ų
• H-Bond Donors: 6
• H-Bond Acceptors: 26
• Rotatable Bonds: 14
• Heavy Atoms: 147
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2010.08
LogP ≤ 5	22.38
H-Bond Donors ≤ 5	6
H-Bond Acceptors ≤ 10	26

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': '>_2_ester_groups', 'substructure': 'N/A'}, {'alert_name': 'phenyl_carbonate', 'substructure': 'N/A'}, {'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one?

The IUPAC name of 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one (CID 157110327) is 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one.

What is the SMILES notation for 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one?

The canonical SMILES for 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one is CCOC(=O)Oc1ccc(-c2nc3c(c(C)nn3C(=O)OCC)c3c2c(=O)[nH]c2cc(N4CCN(C(=O)OCC)CC4)ccc23)cc1.CCOc1[nH]c2cc(N3CCCCC3)ccc2c2c1c(-c1ccc(O)c(C(F)(F)F)c1)nc1ncc(C)c12.CCn1c(=O)c2c(-c3ccc(O)c(C(F)(F)F)c3)nc3[nH]cc(C)c3c2c2ccc(N3CCCCC3)cc21.Cc1[nH]nc2nc(-c3cc(F)cc(F)c3)c3c(=O)n(C)ccc3c12.

What is the InChIKey of 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one?

The InChIKey is PYIRJEOLXKHZBG-UHFFFAOYSA-N. The full InChI is InChI=1S/C33H34N6O8.2C29H27F3N4O2.C17H12F2N4O/c1-5-44-31(41)38-16-14-37(15-17-38)21-10-13-23-24(18-21)34-30(40)27-26(23)25-19(4)36-39(32(42)45-6-2)29(25)35-28(27)20-8-11-22(12-9-20)47-33(43)46-7-3;1-3-36-21-14-18(35-11-5-4-6-12-35)8-9-19(21)24-23-16(2)15-33-27(23)34-26(25(24)28(36)38)17-7-10-22(37)20(13-17)29(30,31)32;1-3-38-28-25-24(19-9-8-18(14-21(19)34-28)36-11-5-4-6-12-36)23-16(2)15-33-27(23)35-26(25)17-7-10-22(37)20(13-17)29(30,31)32;1-8-13-12-3-4-23(2)17(24)14(12)15(20-16(13)22-21-8)9-5-10(18)7-11(19)6-9/h8-13,18H,5-7,14-17H2,1-4H3,(H,34,40);7-10,13-15,37H,3-6,11-12H2,1-2H3,(H,33,34);7-10,13-15,34,37H,3-6,11-12H2,1-2H3;3-7H,1-2H3,(H,20,21,22).

What are the key properties of 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one?

5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one has a molecular weight of 2010.08 g/mol, XLogP of 22.38, 14 rotatable bonds, 6 hydrogen bond donors, and 26 hydrogen bond acceptors.

Where does this data come from?

All data for 5-(3,5-difluorophenyl)-1,7-dimethyl-2H-pyrazolo[4,3-f][2,7]naphthyridin-6-one;4-(9-ethoxy-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,9,11,13,15-octaen-11-yl)-2-(trifluoromethyl)phenol;ethyl 11-(4-ethoxycarbonyloxyphenyl)-5-(4-ethoxycarbonylpiperazin-1-yl)-16-methyl-9-oxo-8,12,14,15-tetrazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaene-14-carboxylate;8-ethyl-11-[4-hydroxy-3-(trifluoromethyl)phenyl]-16-methyl-5-piperidin-1-yl-8,12,14-triazatetracyclo[8.7.0.02,7.013,17]heptadeca-1(17),2(7),3,5,10,12,15-heptaen-9-one is sourced from PubChem (CID 157110327), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).